Navigation Links
Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
Date:4/9/2009

million decrease in the provision of the current income tax with a corresponding reduction in the income tax liability and a $1.1 million increase in deferred income tax expense with an offset to deferred income tax assets. The rate change was recorded in the period that changes occurred.

Three Months Ended December 31, 2008

For the fourth quarter 2008, sales were $12.4 million, compared to $9.2 million in the fourth quarter 2007. The year-over-year increase in sales reflected Sinovac's strategy to continue to devote significant resources to marketing Healive to the private pay market in China, as compared to the market created by government purchasing initiatives under the Expanded Immunization Program that may include the lower priced, live hepatitis A vaccine produced by state owned entities.

During the fourth quarter of 2008, Sinovac sold 1.62 million doses of Healive, compared to 1.14 million doses for the same period of 2007. Sinovac sold 1.05 million doses of Anflu during the fourth quarter of 2008, compared to 0.52 million doses for the same period of the prior year. During the fourth quarter of 2008, Sinovac sold 21,000 doses of Bilive, compared to nil doses in the prior year period. For the fourth quarter of 2008, Healive, Anflu, and Bilive as a percentage of sales represented 78.8%, 1.5% and 19.7%, respectively.

Gross profit for fourth quarter 2008 was $7.7 million, with a gross margin of 63%, compared to $6.3 million, and a gross margin of 68%, for the same period of 2007.

Total operating expenses for the fourth quarter of 2008 were $4.6 million, compared to $3.0 million in the same period 2007. Selling, general and administrative expenses for the fourth quarter of 2008 were $4.1 million, compared to $2.5 million in the same period of 2007. SG&A expenses as a percentage of sales represented 33% in the fourth quarter of 2008, compared to 27% in the sam
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Sinovac Announces Postponement of Annual General Meeting
2. Sinovac Requests Extension for Annual Shareholders Meeting
3. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
4. Sinovac Closes $9.75 Million Private Placement
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. Sinovac Announces Adjournment of Annual General Meeting
7. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results
8. Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results
9. Sinovac Biotech Holds Annual General Meeting
10. Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
11. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 2015   Moleculera Labs today announced ... from the Oklahoma Center for the Advancement of ... development and clinical validation of new diagnostic testing ... in patients experiencing neuropsychiatric disorders such as depression, ... to assist physicians in identifying the subset of ...
(Date:7/7/2015)... ... July 07, 2015 , ... The global aptamers market ... growing at a CAGR of 17.89% between 2015 and 2020. The aptamer type ... Based on applications, the report is segmented into diagnostics, therapeutics development, R&D, and ...
(Date:7/7/2015)... ... July 07, 2015 , ... CSM, a leading clinical trial ... President of Finance. Morse has an extensive background in financial management and accounting, bringing ... team. In his new role, Morse will oversee all financial areas of the company ...
(Date:7/7/2015)... ... 07, 2015 , ... The Pistoia Alliance, a global, not-for-profit ... science R&D, has attracted a number of new members from across the industry. ... joining as a Core member, and DNAnexus and Tessella as Participating members. Genexyx ...
Breaking Biology Technology:Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 2Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 3Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 2Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 3Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 4Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 5CSM Appoints Michael Morse as Vice President of Finance 2Pistoia Alliance Continues to Attract New Members 2
... Broad Institute of MIT and Harvard Deploys Isilon ... Expansion, Enabling Five-Fold Data Growth, SEATTLE, Sept. ... clustered storage, today announced that the Broad,Institute of ... genomics and,biomedical research institutes, has deployed Isilon IQ ...
... VEENENDAAL, Netherlands, September 15 , - Oncentra(R) ... in,Gothenburg, Sweden, September 14-18 and ASTRO 2008, Boston, ... radiation oncology today,announced the market release of Oncentra ... from Nucletron allows clinicians to review,radiotherapy plans that ...
... SYK ) announced that it will host a conference ... Time, to discuss the,Company,s operating results for the quarter ... results for the quarter ended,September 30, 2008 will be ... in the conference call dial 800-299-9630 (domestic) or,617-786-2904 (international) ...
Cached Biology Technology:Isilon IQ Powers Data Storage for Next-Generation DNA Sequencing 2Isilon IQ Powers Data Storage for Next-Generation DNA Sequencing 3Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy 2Stryker to Host Conference Call on October 16, 2008 2
(Date:6/25/2015)... DALLAS , June 25, 2015 ... report "Fingerprint Sensors Market by Type (Swipe & Area), Technology, ... (Mobile, Government, Healthcare, Commercial Security & Others) & ... published by marketsandmarkets, the said market is expected ... CAGR of 17.1%. Browse 76 ...
(Date:6/25/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider, ... and Trademark Office (USPTO) for its "Method for Optimizing ... Accelerators to reduce the time taken to standardize trial ... the accelerators), thus reducing time to market. ... heart of the patented Clinical Data Standardization Process are ...
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... JUPITER, FL, August 24, 2010 - Scientists from the Florida campus ... a critical role in the formation of long-term memory. The findings ... and could lead to novel treatments for memory disorders. The ... Neuron on August 26, 2010. In the study, the ...
... receiving an honour, the American entertainer Jack Benny once said, ... I don,t deserve that either." Unfortunately, Benny was not ... Arthritis is associated with significant discomfort and simple activities such ... painful. A variety of treatments are available, usually involving ...
... The results of a new scientific study from Oxford ... different affects on short-term total energy intake in men and ... Ranawana and Professor Jeya Henry of the Functional Food Centre ... to compare the compensation effect of liquid calories on short-term ...
Cached Biology News:Scripps Research scientists uncover new mechanism of memory formation 2A dog's life -- physiotherapy for arthritic pets 2Research shows gender difference in energy compensation effect 2
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Affinity Purified Rabbit Anti-mouse sRANKL Biotinylated Polyclonal Antibody...
Rabbit polyclonal to FOXJ2 ( Abpromise for all tested applications). entrezGeneID: 55810 SwissProtID: Q9P0K8...
Biology Products: